Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) showed up in the 13F filings of 266 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -108,085 | -0.51% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 482,494 | 2.21% | $0.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 0 | -23,744 | -0.25% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -532,537 | -42.30% | $0.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 0 | 15,827,186 | 0.00% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -703,823 | -11.79% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 48,269 | 906.46% | $0.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Dec, 2025 | 0 | 2,172,000 | 17.85% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -5,516 | -0.15% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | -13,670 | -22.07% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,265,773 | 12.91% | $0.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 0 | 1,619,270 | 117.88% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 7,310,745 | 7,807.21% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | 2,250,000 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,479 | 0.03% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -246,200 | -10.21% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | 95,688 | 2.17% | $0.00 |
| Elmind Capital, LP | 31 Dec, 2025 | 0 | 2,150,000 | 0.00% | $0.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 0 | -151,600 | -3.57% | $0.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 0 | 550,532 | 49.66% | $0.00 |